Delivery Order SPE2DB22D1106-SPE2DB25FFEQ6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,642.74 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $11,258.73 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages). This firm fixed price contract, awarded on August 19, 2025, with completion expected by August 20, 2025, carries no set-aside designation and was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $46,287.17. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 3, 2025. AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $13,341.78 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count). The contract, executed on June 25, 2025, with an ultimate completion date of June 26, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a firm fixed price delivery order from the Defense Logistics Agency's Medical Supply Chain for Otezla 30 mg tablets (60-count units) valued at $35,634.81. This non-set-aside, competitively awarded contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The order represents a standard pharmaceutical supply delivery executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $60,088.59 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $33,358.49 by the Defense Logistics Agency (DLA) for the supply of Otezla 30 mg tablets in quantities of 60. The contract is structured as a firm fixed price delivery order with a completion date of September 2, 2025, and was competitively awarded without set-aside provisions on August 29, 2025. Performance will be executed at the company's corporate office location in...
- The Defense Logistics Agency awarded a $8,629.34 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price contract was issued without set-aside designation and has an ultimate completion date of May 28, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $6,378.35 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 11, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count) under a firm fixed price contract valued at $6,381.96, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEQ6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $56,860.81 to AmerisourceBergen Drug Corp for 60-count bottles of Otezla 30 mg tablets. The contract is non-competitive and utilizes firm fixed pricing, with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen provides a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order represents a routine fulfillment under the company's existing prime contract vehicle, which serves as a flexible procurement mechanism for ongoing pharmaceutical needs across the military medical supply chain. The contract contains no set-aside designation, reflecting AmerisourceBergen's competitive capability to meet federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.9k | 8/21/25 |